Skip to main content
Premium Trial:

Request an Annual Quote

Keygene Buys Illumina Analyzer and Upgrades its 454 Sequencer

NEW YORK (GenomeWeb News) - Keygene said today that it has purchased a 454 GS FLX sequencer from Roche and an Illumina Genome Analyzer.
 
The company upgraded to the GS FLX from a GS 20 and bought the Illumina hardware to "further develop its array of innovative DNA sequence-based applications," the company said today.
 
In early 2006, Keygene bought a GS 20 and a signed a co-marketing collaboration with Roche to market plant genetics applications it developed using the 454 sequencer.
 
The company said it will use the higher-throughput GS FLX to serve its customers' sequencing needs and to support its internal mutation screening and polymorphisms discovery applications. 
 
Keygene said it will use the Illumina analyzer for transcript mapping and for developing applications such as its Amplified Fragment Length Polymorphism method for whole-genome mapping.
 
Financial terms of the deals were not released.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.